Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6276
-0.0798 (-11.28%)
Nov 16, 2026, 1:23 PM EST - Market open

Standard BioTools Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
84.4385.3391.01106.3497.95128.85
Other Revenue
-----1.73
84.4385.3391.01106.3497.95130.58
Revenue Growth
-2.18%-6.24%-14.42%8.57%-24.99%-5.47%
Cost of Revenue
40.3842.7946.1355.8960.999.15
Gross Profit
44.0542.5444.8850.4537.0531.43
Selling, General & Admin
77.18109.86103.0687.54102.2998.89
Research & Development
14.1425.9928.8325.9533.86-
Operating Expenses
91.32135.85131.89113.49136.1498.89
Operating Income
-47.26-93.31-87.01-63.04-99.09-67.46
Interest Expense
-0.03-0.03-3.32-4.57-4.33-3.82
Interest & Investment Income
14.699.1820.25.572.23-
Other Non Operating Income (Expenses)
1.375-5.011.39-60.97.62
EBT Excluding Unusual Items
-31.23-79.16-75.13-60.64-162.09-63.66
Merger & Restructuring Charges
-35.03-16.94-40.48-13.56-13.59-
Gain (Loss) on Sale of Investments
-3.37-0.6----
Asset Writedown
-----3.53-
Other Unusual Items
-3.4-25.21--13.72-
Pretax Income
-73.03-96.7-90.4-74.2-192.93-63.66
Income Tax Expense
-35.8-37.880.540.45-2.83-4.42
Earnings From Continuing Operations
-37.23-58.83-90.94-74.66-190.1-59.24
Earnings From Discontinued Operations
170.3-16.07-47.95---
Net Income
133.08-74.9-138.89-74.66-190.1-59.24
Preferred Dividends & Other Adjustments
--46.01---
Net Income to Common
133.08-74.9-184.9-74.66-190.1-59.24
Net Income Growth
------
Shares Outstanding (Basic)
389382353797876
Shares Outstanding (Diluted)
389382353797876
Shares Change
2.75%8.03%346.24%1.09%3.32%5.19%
EPS (Basic)
0.34-0.20-0.52-0.94-2.43-0.78
EPS (Diluted)
0.34-0.20-0.52-0.94-2.43-0.78
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-65.65-82.65-151.81-46.12-93.2-57.33
Free Cash Flow Per Share
-0.17-0.22-0.43-0.58-1.19-0.76
Gross Margin
52.18%49.86%49.32%47.44%37.83%24.07%
Operating Margin
-55.98%-109.34%-95.60%-59.28%-101.17%-51.66%
Profit Margin
157.62%-87.77%-203.17%-70.20%-194.08%-45.36%
Free Cash Flow Margin
-77.76%-96.85%-166.81%-43.37%-95.15%-43.90%
EBITDA
-38.09-82.33-70.15-47.86-84.06-63.81
EBITDA Margin
-45.12%-96.48%-77.08%-45.01%-85.82%-48.86%
D&A For EBITDA
9.1710.9816.8615.1815.033.65
EBIT
-47.26-93.31-87.01-63.04-99.09-67.46
EBIT Margin
-55.98%-109.34%-95.60%-59.28%-101.17%-51.66%
Revenue as Reported
84.4385.3391.01106.3497.95130.58
Advertising Expenses
-2.22.62-3.4
SEC Filings: 10-K · 10-Q